Your browser doesn't support javascript.
loading
Can Timely Outpatient Visits Reduce Readmissions and Mortality Among Heart Failure Patients?
Balasubramanian, Ishwarya; Malhotra, Chetna.
Afiliación
  • Balasubramanian I; Duke-NUS Medical School, Lien Centre for Palliative Care, Singapore, Singapore.
  • Malhotra C; Duke-NUS Medical School, Lien Centre for Palliative Care, Singapore, Singapore. chetna.malhotra@duke-nus.edu.sg.
J Gen Intern Med ; 2024 Apr 10.
Article en En | MEDLINE | ID: mdl-38600403
ABSTRACT

BACKGROUND:

Outpatient follow-up after a hospital discharge may reduce the risk of readmissions, but existing evidence has methodological limitations.

OBJECTIVES:

To assess effect of outpatient follow-up within 7, 14, 21 and 30 days of a hospital discharge on 30-day unplanned readmissions or mortality among heart failure (HF) patients; and whether this varies for patients with different clinical complexities.

DESIGN:

We analyzed medical records between January 2016 and December 2021 from a prospective cohort study. Using time varying mixed effects parametric survival models, we examined the association between not having an outpatient follow-up and risk of adverse events. We used interaction models to assess if the effect of outpatient follow-up visit on outcomes varies with patients' clinical complexity (comorbidities, grip strength, cognitive impairment and length of inpatient stay).

PARTICIPANTS:

Two hundred and forty-one patients with advanced HF. MAIN

MEASURES:

30-day all-cause (or cardiac) adverse event defined as all cause (or cardiac) unplanned readmissions or death within 30 days of an unplanned all-cause (or cardiac) admission or emergency department visit. KEY

RESULTS:

We analyzed 1595 all-cause admissions, inclusive of 1266 cardiac admissions. Not having an outpatient follow-up (vs having an outpatient follow-up) significantly increased the risk of 30-day all-cause adverse event. (risk [95% CI] - 14 days 35.1 [84.5,-1.1]; 21 days 43.9 [48.2,6.7]; 30 days 31.1 [48.5, 7.9]) The risk (at 21 days) was higher for those with one co-morbidity (0.25 [0.11,0.58]), mild (0.67 [0.45, 1.00]) and moderate cognitive impairment (0.38 [0.17, 0.84]), normal grip strength (0.57 [0.34, 0.96]) and length of inpatient stay 7-13 days (0.45 [0.23, 0.89]).

CONCLUSION:

Outpatient follow-up within 30 days after a hospital discharge reduced risk of 30-day adverse events among HF patients, the benefit varying according to clinical complexity. Results suggest the need to prioritize patients who benefit from outpatient follow-up for these visits.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Gen Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Gen Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article País de afiliación: Singapur